These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21879468)

  • 1. Interleukin-6 and its considerable role in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in postmenopausal women.
    Mysliwiec J; Adamczyk M; Nikolajuk A; Gorska M
    Endokrynol Pol; 2011; 62(4):299-302. PubMed ID: 21879468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice.
    Mysliwiec J; Zbucki R; Winnicka MM; Sawicki B; Nikolajuk A; Kaminski K; Mysliwiec P; Musial W; Bondyra Z; Walecki J; Gorska M
    Horm Metab Res; 2007 Dec; 39(12):884-8. PubMed ID: 17973207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
    Qin YJ; Zhang ZL; Zhang H; Hu WW; Liu YJ; Hu YQ; Li M; Gu JM; He JW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
    Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
    Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 is not essential for bone turnover in hypothyroid mice.
    Mysliwiec J; Zbucki R; Winnicka M; Sawicki B; Nikolajuk A; Kaminski K; Mysliwiec P; Musial W; Bondyra Z; Walecki J; Gorska M
    Folia Histochem Cytobiol; 2007; 45(4):387-92. PubMed ID: 18165179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
    Insogna K; Mitnick M; Pascarella J; Nakchbandi I; Grey A; Masiukiewicz U
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of interleukin-1 and -6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children.
    Rusińska A; Chlebna-Sokół D
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):257-65. PubMed ID: 15995586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
    J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis.
    Wu Q; Zhong ZM; Pan Y; Zeng JH; Zheng S; Zhu SY; Chen JT
    Med Sci Monit; 2015 Aug; 21():2428-32. PubMed ID: 26286507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens modulate RANKL-RANK/osteoprotegerin mediated interleukin-6 effect on thyrotoxicosis-related bone turnover in mice.
    Mysliwiec J; Zbucki R; Nikolajuk A; Mysliwiec P; Kaminski K; Bondyra Z; Dadan J; Gorska M; Winnicka MM
    Horm Metab Res; 2011 Apr; 43(4):236-40. PubMed ID: 21332025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
    Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Penttilä IM; Rauramaa R
    Bone; 2004 Aug; 35(2):439-47. PubMed ID: 15268895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
    J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sex and age on biochemical bone metabolism parameters.
    Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
    Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
    Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G
    J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of aromatase inhibitor-associated bone loss by shugan jiangu recipe in postmenopausal women with breast cancer: a clinical study].
    Li YQ; Sun H; Xue D; Xu YC; Li ZD; Wang W; Li PP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1064-8. PubMed ID: 25335329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.